Ophthalmology Doctors in Asheville, NC Accepting Medicare

28 Ophthalmology doctors found. Showing 21 - 28

Jeffrey Brian Goldstein, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8 Medical Park Dr, Asheville, NC 28803 Phone: 828-258-1586    Fax: 828-258-6161

Dr. Albert Bernard Anderson, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 141 Asheland Ave, Asheville, NC 28801 Phone: 828-252-6922    Fax: 828-252-6989

Dr. Mark A Joseph, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Vanderbilt Park Dr, Suite 150, Asheville, NC 28803 Phone: 828-693-1773    Fax: 828-692-3297

James David Crandall, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8 Medical Park Dr, Asheville, NC 28803 Phone: 828-258-1586    Fax: 828-258-6161

Cameron Mclure Stone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 21 Medical Park Dr, Asheville, NC 28803 Phone: 828-255-8978    Fax: 828-251-9150

C Diane Song, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1100 Tunnel Rd, Asheville, NC 28805 Phone: 828-298-7911    Fax: 828-299-2577

Winston C Payne, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 900 Centrepark Drive, Ste A, Asheville, NC 28805 Phone: 828-254-9693    Fax: 828-254-9695

Walter Hawkins Brosnan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 900 Centrepark Drive, Ste A, Asheville, NC 28805 Phone: 828-254-9693    Fax: 828-254-9695

News Archive

TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

TauRx Therapeutics Ltd has achieved its target enrolment of 700 subjects with mild Alzheimer's disease into the second of its two Phase III clinical trials of LMTX, a tau aggregation inhibitor, for the treatment of Alzheimer's disease.

See salad, eat fries: When healthy menus backfire

Just seeing a salad on the menu seems to push some consumers to make a less healthy meal choice, according a Duke University researcher.

Generic aromatase inhibitors increase breast cancer treatment adherence by 50%

Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.

Researchers shed light on the dual action of aspirin

Hugely popular non-steroidal anti-inflammation drugs like aspirin, naproxen (marketed as Aleve) and ibuprofen (Advil, Motrin) all work by inhibiting or killing an enzyme called cyclooxygenase - a key catalyst in production of hormone-like lipid compounds called prostaglandins that are linked to a variety of ailments, from headaches and arthritis to menstrual cramps and wound sepsis.

Longer looks: The timely trauma response in Boston; Problems with aging doctors; Transplants from donors with HIV

The bombs at the Boston Marathon were designed to maim and kill, and they did. Three people died within the first moments of the blast. More than a hundred and seventy people were injured. They had their limbs blown off, vital arteries severed, bones fractured, flesh torn open by shrapnel or scorched by the blasts' heat. Yet it now appears that every one of the wounded alive when rescuers reached them will survive.

Read more Medical News

› Verified 4 days ago

• 1
• 2(current)